Magnus Muller, the 24-year-old CEO of the AI startup Browser Use, works seven days a week from the time he rises (reportedly ...
ORR for BI-1808 combined with pembrolizumab represents a meaningful improvement over pembrolizumab monotherapy in recurrent ovarian cancer (8% ORR in KEYNOTE-100) The combination demonstrated a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results